Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Treg suppression of immunity within inflamed allogeneic grafts
Hehua Dai, Andressa Pena, Lynne Bauer, Amanda Williams, Simon C. Watkins, Geoffrey Camirand
Hehua Dai, Andressa Pena, Lynne Bauer, Amanda Williams, Simon C. Watkins, Geoffrey Camirand
View: Text | PDF
Research Article Immunology Transplantation

Treg suppression of immunity within inflamed allogeneic grafts

  • Text
  • PDF
Abstract

CD4+Foxp3+ regulatory T cells (Tregs) restrain inflammation and immunity. However, the mechanisms underlying Treg suppressor function in inflamed nonlymphoid tissues remain largely unexplored. Here, we restricted immune responses to nonlymphoid tissues and used intravital microscopy to visualize Treg suppression of rejection by effector T cells (Teffs) within inflamed allogeneic islet transplants. Despite their elevated motility, Tregs preferentially contacted antigen-presenting cells (APCs) over Teffs. Interestingly, Tregs specifically targeted APCs that were extensively and simultaneously contacted by Teffs. In turn, Tregs decreased MHC-II expression on APCs and hindered Teff function. Last, we demonstrate that Treg suppressive function within inflamed allografts required ectonucleotidase CD73 activity, which generated the antiinflammatory adenosine. Consequently, CD73–/– Tregs exhibited fewer contacts with APCs within inflamed allografts compared with WT Tregs, but not in spleen. Overall, our findings demonstrate that Tregs suppress immunity within inflamed grafts through CD73 activity and suggest that Treg-APC direct contacts are central to this process.

Authors

Hehua Dai, Andressa Pena, Lynne Bauer, Amanda Williams, Simon C. Watkins, Geoffrey Camirand

×

Figure 5

Tregs reduce expression of both MHC-II on APCs and IFN-γ in Teffs within allografts.

Options: View larger image (or click on image) Download as PowerPoint
Tregs reduce expression of both MHC-II on APCs and IFN-γ in Teffs within...
Innate immune cells were characterized by flow cytometry from islet allografts of mice lacking SLOs (as described in Figure 1A), 7 days after cell transfer. (A) Tregs significantly reduce MHC-II, but not CD80 and CD86, expression levels on CD11c+MHC-II+ innate cells within allografts. Relative mean geometric MFI of MHC-II, CD80, and CD86 expression levels on live CD45+Lin–CD11c+MHC-II+ cells within islet allografts. n = 4–6 mice per group from 2–3 independent experiments. (B) Tregs reduce IFN-γ expression in Teffs within allografts. Percentage (left) and absolute cell numbers (right) of IFN-γ–expressing CD4+ and CD8+ Teffs by direct in vivo cytokine assessment. n = 5 per group from 2 independent experiments. Each square represents data from 1 mouse and horizontal bars show median. Mann-Whitney tests used. *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts